PTGS2 and primary failure of tooth eruption: In the secondary efficacy outcomes, there were no statistically significant differences in the COMP, COX-2, HS-CRP and ESR levels, and the neutrophil and lymphocyte ratio in the PFE group compared with the placebo group at the end of the intervention (Table 3).